These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3228113)

  • 21. Cefotetan versus cefoxitin in the treatment of patients with biliary sepsis assessed by a biliary sepsis score.
    Basoli A; Schietroma M; Fiocca F; Vigliardi G; Speranza V
    J Chemother; 1989 Jul; 1(4 Suppl):825-7. PubMed ID: 16312657
    [No Abstract]   [Full Text] [Related]  

  • 22. Cost-effectiveness study of cefotetan versus cefoxitin and cefotetan versus combination antibiotic regimens.
    Sochalski A; Sullman S; Andriole VT
    Am J Surg; 1988 May; 155(5A):96-101. PubMed ID: 3132048
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoting the cost-effective utilization of cefoxitin with a drug use education program.
    Wein PJ; Hoffman RP
    Hosp Formul; 1987 Mar; 22(3):299-306. PubMed ID: 10312016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective comparative study of cefotetan versus cefoxitin against infection in elective colorectal surgery.
    Basoli A; Schietroma M; Fiocca F; Vigliardi G; Speranza V
    J Chemother; 1989 Jul; 1(4 Suppl):999-1001. PubMed ID: 16312742
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative clinical and pharmacokinetic aspects of cefotetan versus cefoxitin plus metronidazole in vaginal hysterectomy.
    Engel K; Schmidt W; Sonntag HG; Kees F
    J Chemother; 1989 Jul; 1(4 Suppl):1053-6. PubMed ID: 16312768
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of cefotetan in clindamycin-induced enterocolitis in hamsters.
    Dubini F
    Chemioterapia; 1988 Jun; 7(3):147-50. PubMed ID: 3168068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and cost implications of the new cephalosporins. Vancouver, British Columbia, Canada, August 21-22, 1987. Proceedings.
    Am J Obstet Gynecol; 1988 Mar; 158(3 Pt 2):687-746. PubMed ID: 3162651
    [No Abstract]   [Full Text] [Related]  

  • 28. The conversion of cefoxitin usage to cefotetan: an interdisciplinary approach.
    Nightingale CH; Smith KS; Quintiliani R; Briceland LL; Cooper B
    Am J Surg; 1988 May; 155(5A):101-2. PubMed ID: 3163897
    [No Abstract]   [Full Text] [Related]  

  • 29. Projected cost savings associated with cefmetazole: a new cephamycin for the hospitalized patient.
    Crane VS
    Hosp Formul; 1991 Apr; 26(4):302-6, 309-10. PubMed ID: 10109799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A cost effective approach to surgical antibiotic prophylaxis.
    Pavan MM; Malyuk DL
    Can J Hosp Pharm; 1992 Aug; 45(4):151-6. PubMed ID: 10123058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cefoxitin use review.
    Lazor-Bajcar JM
    Can J Hosp Pharm; 1990 Oct; 43(5):221-5, xxxii. PubMed ID: 10107924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cefotetan: comparative and noncomparative studies in obstetric and gynecologic infections.
    Knuppel RA; O'Bryan D; Lake M
    South Med J; 1988 Feb; 81(2):185-8. PubMed ID: 3422519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of clinical pharmacists to reduce cefamandole, cefoxitin, and ticarcillin costs.
    Abramowitz PW; Nold EG; Hatfield SM
    Am J Hosp Pharm; 1982 Jul; 39(7):1176-80. PubMed ID: 7114059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotics in tactical combat casualty care 2002.
    Butler F; O'Connor K
    Mil Med; 2003 Nov; 168(11):911-4. PubMed ID: 14680047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug cost containment in the hospital.
    Smith WE
    Hosp Formul; 1978 Sep; 13(9):695-8. PubMed ID: 10238490
    [No Abstract]   [Full Text] [Related]  

  • 36. An automatic substitution policy for cefazolin.
    Nakagawa RS
    Can J Hosp Pharm; 1986 Aug; 39(4):105-6. PubMed ID: 10278469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of cefoxitin and ceftizoxime in a hospital therapeutic interchange program.
    Martinusen S; Chen D; Frighetto L; Bunz D; Stiver HG; Jewesson PJ
    CMAJ; 1993 Apr; 148(7):1161-9. PubMed ID: 8457957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A lab-pharmacy push to cut drug therapy costs.
    Rydzewski MM
    MLO Med Lab Obs; 1984 Oct; 16(10):63-4, 69. PubMed ID: 10268396
    [No Abstract]   [Full Text] [Related]  

  • 39. Automatic interchange and selective culture and sensitivity reporting of cefazolin sodium.
    Oh T; Franko TG; Rumsey KR; Dominguez C
    Am J Hosp Pharm; 1988 Jun; 45(6):1278. PubMed ID: 3414693
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro antibacterial activity of cefoxitin and cefotetan and pharmacokinetics in dogs.
    Petersen SW; Rosin E
    Am J Vet Res; 1993 Sep; 54(9):1496-9. PubMed ID: 8239139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.